구미 보충제 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Gummy Supplements Market was valued at USD 10.7 billion in 2024 and is estimated to grow at a CAGR of 9.5% to reach USD 27.1 billion by 2034. Gummy supplements provide a chewable, candy-like alternative to traditional pills and capsules, making dietary supplements more appealing, especially to those who dislike swallowing tablets, such as children. While these supplements often contain essential vitamins, minerals, or other nutrients, challenges like high sugar content, artificial flavors, and limited shelf life exist. However, ongoing advancements in research and development, including innovations in packaging and formulation technologies, are addressing these issues effectively. Market growth is fueled by rising consumer demand for convenient, flavorful, and easy-to-consume supplement options. Gummy supplements cater to various health needs, including immunity support, digestive health, and better sleep. Trends toward clean labeling, improved formulations, and expanded availability across both offline and online retail channels are further accelerating market expansion. Overall, the industry benefits from a growing focus on preventive nutrition, health, wellness, and sustainability concerns, highlighting significant growth opportunities worldwide.

The vitamins segment accounted for a 36.2% share and was valued at USD 3.9 billion in 2024. This segment remains dominant due to the widespread use of single vitamins like Vitamin C, D, and B complex, as well as multivitamins addressing daily nutritional requirements for all age groups. Vitamins such as C and D are highly favored for immunity and bone health, while the B complex supports energy metabolism and the nervous system. Modern gummy supplements incorporate fruity flavors, making them enjoyable and widely accepted by consumers.

The offline retail channels segment held a 75.3% share in 2024 and is expected to grow at a CAGR of 7.5%, by 2034. The dominance of offline channels stems from their accessibility, instant product availability, and the ability for customers to examine products before purchase. In-person consultations, real-time stock displays, and personalized customer service build confidence, particularly for first-time users. This channel includes supermarkets, pharmacies, specialty stores, and other physical retail locations.

North America Gummy Supplements Market held a 38.8% share in 2024. The United States plays a central role within the region, driven by a well-established supplement consumption culture, high consumer health awareness, and widespread product availability. Prominent U.S.-based brands have extensive distribution networks spanning pharmacies, supermarkets, and e-commerce platforms, catering effectively to consumer demands and fueling market growth.

Key players shaping the Global Gummy Supplements Market include Pfizer Inc., Bayer AG, Nestle Health Science, Unilever, and Amway Corp. To strengthen their foothold in the gummy supplements market, companies focus heavily on product innovation, developing cleaner labels and healthier formulations such as reduced sugar and natural ingredients to meet evolving consumer preferences. Expanding distribution channels, particularly in e-commerce and brick-and-mortar retail, allows brands to reach a broader audience. Firms invest in marketing campaigns that emphasize the convenience, taste, and health benefits of gummy supplements to attract new consumers, including children and adults seeking easy supplement options. Sustainability initiatives in packaging and production are prioritized to appeal to environmentally conscious buyers.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 End Use
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier Landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
  • 3.6.1 Technology and innovation landscape
  • 3.6.2 Current technological trends
  • 3.6.3 Emerging technologies
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By product
• 3.8 Future market trends
• 3.9 Technology and innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly Initiatives

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2021 - 2034 (USD Million) (Kilo Tons)

• 5.1 Key trends
• 5.2 Vitamins
  • 5.2.1 Single vitamins
    • 5.2.1.1 Vitamin C
    • 5.2.1.2 Vitamin D
    • 5.2.1.3 Vitamin B complex
    • 5.2.1.4 Others
  • 5.2.2 Multivitamins
• 5.3 Minerals
  • 5.3.1 Calcium
  • 5.3.2 Zinc
  • 5.3.3 Magnesium
  • 5.3.4 Iron
  • 5.3.5 Others
• 5.4 Botanical and herbal extracts
  • 5.4.1 Elderberry
  • 5.4.2 Turmeric
  • 5.4.3 Ashwagandha
  • 5.4.4 Others
• 5.5 Specialty nutrients
  • 5.5.1 Omega 3 fatty acids
  • 5.5.2 Collagen
  • 5.5.3 Coenzyme Q10
  • 5.5.4 Others
• 5.6 Probiotics and prebiotics
• 5.7 Others

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 (USD Million) (Kilo Tons)

• 6.1 Key trends
• 6.2 Immune health
• 6.3 Digestive health
• 6.4 Bone and joint health
• 6.5 Heart health
• 6.6 Brain and cognitive health
• 6.7 Sleep and stress management
• 6.8 Weight management
• 6.9 Beauty and skin health
• 6.10 Others

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 (USD Million) (Kilo Tons)

• 7.1 Key trends
• 7.2 Online
  • 7.2.1 E-commerce platforms
  • 7.2.2 Company websites
  • 7.2.3 Online pharmacies
• 7.3 Offline
  • 7.3.1 Supermarkets and hypermarkets
  • 7.3.2 Pharmacies and drug stores
  • 7.3.3 Specialty stores
  • 7.3.4 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Million) (Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Nestle Health Science
• 9.2 Bayer AG
• 9.3 Pfizer Inc.
• 9.4 Church & Dwight Co., Inc.
• 9.5 The Clorox Company (Rainbow Light)
• 9.6 Pharmavite LLC (Nature Made)
• 9.7 Haleon plc (formerly GSK Consumer Healthcare)
• 9.8 Herbalife Nutrition Ltd.
• 9.9 Olly PBC
• 9.10 SmartyPants Vitamins
• 9.11 Glanbia plc
• 9.12 Procaps Group S.A.
• 9.13 Amway Corp.
• 9.14 Unilever (OLLY)
• 9.15 The Honest Company